Literature DB >> 11055282

Biomaterial developments for bone tissue engineering.

K J Burg1, S Porter, J F Kellam.   

Abstract

The development of bone tissue engineering is directly related to changes in materials technology. While the inclusion of materials requirements is standard in the design process of engineered bone substitutes, it is also critical to incorporate clinical requirements in order to engineer a clinically relevant device. This review presents the clinical need for bone tissue-engineered alternatives to the present materials used in bone grafting techniques, a status report on clinically available bone tissue-engineering devices, and recent advances in biomaterials research. The discussion of ongoing research includes the current state of osseoactive factors and the delivery of these factors using bioceramics and absorbable biopolymers. Suggestions are also presented as to the desirable design features that would make an engineered device clinically effective.

Mesh:

Substances:

Year:  2000        PMID: 11055282     DOI: 10.1016/s0142-9612(00)00102-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  195 in total

1.  Biocompatibility and biodegradation studies of PCL/β-TCP bone tissue scaffold fabricated by structural porogen method.

Authors:  Lin Lu; Qingwei Zhang; David Wootton; Richard Chiou; Dichen Li; Bingheng Lu; Peter Lelkes; Jack Zhou
Journal:  J Mater Sci Mater Med       Date:  2012-06-06       Impact factor: 3.896

Review 2.  Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their applications to tissue engineering and regenerative medicine.

Authors:  Byung-Chul Kim; Hojae Bae; Il-Keun Kwon; Eun-Jun Lee; Jae-Hong Park; Ali Khademhosseini; Yu-Shik Hwang
Journal:  Tissue Eng Part B Rev       Date:  2012-03-06       Impact factor: 6.389

3.  Modulating the rigidity and mineralization of collagen gels using poly(lactic-co-glycolic acid) microparticles.

Authors:  Ross J DeVolder; Il Won Kim; Eun-Suk Kim; Hyunjoon Kong
Journal:  Tissue Eng Part A       Date:  2012-06-26       Impact factor: 3.845

4.  Injectable tissue-engineered bone repair of a rat calvarial defect.

Authors:  Scott J Stephan; Sunil S Tholpady; Brian Gross; Caren E Petrie-Aronin; Edward A Botchway; Lakshmi S Nair; Roy C Ogle; Stephen S Park
Journal:  Laryngoscope       Date:  2010-05       Impact factor: 3.325

5.  Enhanced cell ingrowth and proliferation through three-dimensional nanocomposite scaffolds with controlled pore structures.

Authors:  Kee-Won Lee; Shanfeng Wang; Mahrokh Dadsetan; Michael J Yaszemski; Lichun Lu
Journal:  Biomacromolecules       Date:  2010-03-08       Impact factor: 6.988

6.  Materiomics for Oral Disease Diagnostics and Personal Health Monitoring: Designer Biomaterials for the Next Generation Biomarkers.

Authors:  Wenjun Zhang; Ming L Wang; Sammy Khalili; Steven W Cranford
Journal:  OMICS       Date:  2016-01

7.  Biocompatible hydrophilic brushite coatings on AZX310 and AM50 alloys for orthopaedic implants.

Authors:  Y Sasikumar; A Madhan Kumar; R Suresh Babu; Mohammad Mizanur Rahman; Leandro M Samyn; A L F de Barros
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

8.  Dexamethasone-loaded hydroxyapatite enhances bone regeneration in rat calvarial defects.

Authors:  Reza Tavakoli-darestani; Alireza Manafi-rasi; Amin Kamrani-rad
Journal:  Mol Biol Rep       Date:  2013-11-27       Impact factor: 2.316

9.  Controlling stem cell-mediated bone regeneration through tailored mechanical properties of collagen scaffolds.

Authors:  Hongli Sun; Feng Zhu; Qingang Hu; Paul H Krebsbach
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

Review 10.  Silicon micro- and nanofabrication for medicine.

Authors:  Daniel Fine; Alessandro Grattoni; Randy Goodall; Shyam S Bansal; Ciro Chiappini; Sharath Hosali; Anne L van de Ven; Srimeenkashi Srinivasan; Xuewu Liu; Biana Godin; Louis Brousseau; Iman K Yazdi; Joseph Fernandez-Moure; Ennio Tasciotti; Hung-Jen Wu; Ye Hu; Steve Klemm; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2013-04-15       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.